Cytokines and inflammatory bowel disease

Bailliere's Clinical Gastroenterology

Volumn 10, Issue 1, 1996, Pages 151-164

  Radford Smith, Graham ^a   Jewell, Derek P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOKINE; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; GASTROINTESTINAL MUCOSA; GENE EXPRESSION; GENETIC POLYMORPHISM; HELPER CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 0029926211     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(96)90045-7     Document Type: Article

References (64)

1. Andus T, Targan SR, Deem R et al (1993) Measurement of tumor necrosis factor alpha mRNA in small numbers of cells by quantitative polymerase chain reaction. Regional Immunology 5(1): 11-17.
2. Bailly S, di Giovine F, Blakemore AI et al (1993) Genetic polymorphism of human interleukin-1 alpha. European Journal of Immunology 23(6): 1240-1245.
3. Barnard JA, Beauchamp RD, Coffey RJ et al (1989) Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proceedings of the National Academy of Sciences of the USA 86(5): 1578-1582.
4. Breese E, Braegger CP, Corrigan CJ et al (1993) Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78(1): 127-131.
5. Bromley L, McCarthy SP, Strickland JE et al (1994) Non-isotopic in situ detection of mRNA for interleukin-4 in archival human tissue. Journal of Immunological Methods 167: 47-54.
6. Caceres DG, Tapia FJ, Sanchez MA et al (1993) Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clinical and Experimental Immunology 91(3): 500-505.
7. Capello M, Keshav S, Prince C et al (1992) Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridization. Gut 33(9): 1214-1219.
8. Ciacci C, Mahida YR, Dignass A et al (1993) Functional interleukin-2 receptors on intestinal epithelial cells. Journal of Clinical Investigation 92(1): 527-532.
9. Colgan SP, Parkos CA, Delp C et al (1993) Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IGF-gamma in a highly polarized fashion. Journal of Cell Biology 120(3): 785-798.
10. Cominelli F, Nast CC, Clark BD et al (1990) Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. Journal of Clinical Investigation 86(3): 972-980.
11. Cominelli F, Kam L, Casini-Raggi V et al (1994) Specific mucosal imbalance of IL-1 and IL-1 receptor antagonist (IL-1ra) in IBD: a potential mechanism of chronic inflammation. Gastroenterology 106: A667.
12. de Waal Malefyt R, Haanen RJ, Spits H et al (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. Journal of Experimental Medicine 174(4): 915-924.
13. Giovine F, Takhsh E, Blakemore AI et al (1992) Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Human Molecular Genetics 1(6): 450.
14. Dignass AU & Podolsky DK (1993) Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 105(5): 1323-1332.
15. Eckmann L, Jung HC, Schurer-Maly C (1993) Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 105(6): 1689-1697.
16. Eisenberg SP, Evans RJ, Arend WP et al (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343(6256): 341-346.
17. Fais S, Capobianchi MR, Pallone F et al (1991) Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. Gut 32(4): 403-407.
18. Fiocchi C, Hilfiker ML, Youngman KR et al (1984) Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 86(4): 734-742.
19. Gibson P & Rosella O (1994) Interleukin-8 secretion by colonie epithelial cells in vitro: modulation and effect of disease. Gastroenterology 106: A687.
20. Grimm M, Elsbury S, Van de Pol E et al (1994) Increased chemokine expression by lamina propria cells in inflammatory bowel disease. Gastroenterology 106: A693.
21. Gross V, Andus T, Caesar I et al (1992) Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 102(2): 514-519.
22. Isaacs KL, Sartor RB. Haskill S et al (1992) Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103(5): 1587-1595.
23. Kelly CP, O'Keane JC, Orellana J et al (1992) Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. American Journal of Physiology 263: G864-G870.
24. Kühn R, Lohler J, Rennick D et al (1993) Interleukin-10-deficient mice develop chronic enterocolitis Cell 75(2): 263-274 (see comments).
25. Leser HG, Gross V, Scheibenbogen C et al (1991) Evaluation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 101(3): 782-785.
26. Lieberman BY, Fiocchi C, Youngman KR et al (1988) Interferon γ production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Digestive Diseases and Sciences 33: 1297-1304.
27. Lobo A, Evans S, Jones SC et al (1992) Plasma interleukin-6 in inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 4: 367-372.
28. Maggi E, Parronchi P, Manetti R et al (1992) Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. Journal of Immunology 148(7): 2142-2147.
29. Mahida YR, Wu K, Jewell DP et al (1989) Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 30(6): 835-838.
30. Mahida YR, Ceska M, Effenberger F et al (1992) Enhanced synthesis of neutrophil-activating peptide-l/interleukin-8 in active ulcerative colitis. Clinical Science 82(3): 273-275.
31. Mansfield JC, Holden H, Tarlow JK et al (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106(3): 637-642.
32. Matsuura T, West GA, Youngman KR et al (1993a) Immune activation gene products are resistant to IL4 inhibitory activity in Crohn's disease (CD). Gastroenterology 104: A739.
33. Matsuura T, West GA, Klein JS et al (1993b) Immune activation genes in inflammatory bowel disease. Gastroenterology 104(2): 448-458.
34. Mitsuyama K, Sata M, Tanikawa K et al (1991) Significance of interleukin-6 in patients with inflammatory bowel disease. Gastroenterologica Japonica 26(1): 20-28.
35. Mosmann TR & Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 7(1): 145-173.
36. Mullin GE, Lazenby AJ, Harris ML et al (1992) Increased interleukin-2 messenger RNA in the intestinal raucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 102(5): 1620-1627.
37. Mullin G, Vezza F, Sampat A et al (1993) Abnormal IL10 mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 104: A751.
38. Mullin G, Maycon Z, Katz R et al (1994) IL-13 in the mucosal lesions of inflammatory bowel disease. Gastroenterology 106: A740.
39. Murch SH, Braegger CP, Walker-Smith JH et al (1993) Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34(12): 1705-1709.
40. Oswald IP, Gazzinelli RT, Sher A & James SL (1992) IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. Journal of Immunology 148(11): 3578-3582.
41. Plevy S, Targan S, Rotter I & Toyoda H et al (1994) Tumour necrosis factor (TNF) microsatellite associations within HLA-DR2+ patients define Crohn's disease (CD) and ulcerative colitis (UC)-specific genotypes. Gastroenterology 106: A754.
42. Powrie F, Correa OR, Mauze S & Coffman RL (1994) Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. Journal of Experimental Medicine 179(2): 589-600.
43. Pullman WE & Doe WF (1992) IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons. Clinical and Experimental Immunology 88(1): 132-137.
44. Radford-Smith GL (1994) Cytokine gene expression in inflammatory bowel disease. D.Phil Oxford.
45. Radford-Smith GL, McGowan I & Jewell DP (1994a) Th1 and Th2 cytokine gene expression in inflammatory bowel disease. Gastroenterology 106(4): A757.
46. Radford-Smith GL, Nakamuta K, Zimmerman M et al (1994b) Immunoregulatory cytokine production by lamina propria mononuclear cells from patients with inflammatory bowel disease and controls. Gut 35 (supplement 5):
47. Radford-Smith GL, McGowan I, Jewell DP et al (1994c) Upregulation of interleukin 4 mRNA in inflamed intestinal mucosa. Is this increase real or apparent? Gut 35 (supplement 5): T119.
48. Reinecker HC, Steffen M, Wittocft T et al (1993) Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clinical and Experimental Immunology 94(1): 174-281.
49. Sadlack B, Merz H, Schorle H et al (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75(2): 253-261.
50. Sasaki T, Hiwatashi N, Yamazaki H et al (1992) The role of Interferon gamma in the pathogenesis of Crohn's disease. Gastroenterologica Japonica 27(1): 29-36.
51. Satsangi J, Rosenberg W, Jewell DP et al (1994) The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. European Journal of Gastroenterology and Hepatology 6: 413-416.
52. Schall TJ, Bacon K, Toy KJ & Goeddel DV et al (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347(6294): 669-671.
53. Schreiber S, Blum J, Howaldt S et al (1993) Deactivation of intestinal macrophages and induction of mannose receptor expression by interleukin 4: defective regulation in IBD. Gastroenterology 104: A776.
54. Shull MM, Ormsby I, Kier AB et al (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359(6397): 693-699.
55. Stallmach A, Schuppan D, Riese HH et al (1992) Increased type III collagen by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 102: 1920-1929.
56. Stevens C, Walz G, Singaram C et al (1992) Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Digestive Diseases and Science 37(6): 818-826.
57. Tanaka Y, Adams DH, Hubscher S et al (1993) T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361(6407): 79-82.
58. Tarlow JK, Blakemore AI, Lennard A et al (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Human Genetics 91(4): 403-404.
59. Theodorou V, Eutamene H, Fioramonti J et al (1994) Interleukin 1 induces a neurally mediated colonie secretion in rats: involvement of mast cells and prostaglandins. Gastroenterology 106: 1493-1500.
60. van Dulleman H, Hommes D, Meenan J et al (1994) Complete remission of steroid-refractory Crohn's disease after administration of monoclonal anti-TNF antibody. Gastroenterology 106: A1054.
61. Wilson AG, de Vries N, Pociot F et al (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. Journal of Experimental Medicine 177(2): 557-560.
62. Woloski BM, Smith EM, Meyer WJ et al (1985) Corticotropin-releasing activity of monokines. Science 230(4729): 1035-1037.
63. Yamamura M, Uyemura K, Deans RJ et al (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254(5029): 277-279.
64. Youngman KR, Simons PL, West GA et al (1993) Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 104(3): 749-758.